API business of Dr. Reddy’s reports fall in sales

8:25 AM MST | November 4, 2013 | Deepti Ramesh

The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 19% fall in sales in the company’s fiscal second quarter, ended 30 September, compared with the year-ago quarter, to 6.4 billion Indian rupees ($103 million), because of fewer launch molecules to customers during the quarter, Dr. Reddy’s says. Earnings figures for the PSAI business have not been disclosed. During the quarter, eight drug master files (DMF) were filed globally, including one in the United States, Dr...